Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Nitroglycerin for treatment of retained placenta: a randomized, placebo-controlled, multicentre double blind trial in the UK

Denison FC. et al, (2019), PLoS Medicine

CLINICIAN-RESEARCHERS AND CUSTODIANS OF SCARCE RESOURCES: A QUALITATIVE STUDY OF HEALTH PROFESSIONALS’ VIEWS ON BARRIERS TO TEENAGERS AND YOUNG ADULTS’ INVOLVEMENT IN CANCER TRIALS

Hart RI. et al, (2019), Trials

Enabling Global Clinical Collaborations on Identifiable Patient Data: The Minerva Initiative

Nellåker C. et al, (2019), Frontiers in Genetics, 10

Does the type of disease matter when receiving secondary findings? A qualitative vignette study on Finnish adults' views

Vornanen M. et al, (2019), EUROPEAN JOURNAL OF HUMAN GENETICS, 27, 716 - 716

Mainstreaming BRCA1 and BRCA2 testing: an interview study of healthcare professionals' views

Wright S. et al, (2019), EUROPEAN JOURNAL OF HUMAN GENETICS, 27, 664 - 665

Moving into the mainstream: Treatment focussed genetic testing a screening tool or diagnostic resource?

Hallowell N. et al, (2019), EUROPEAN JOURNAL OF HUMAN GENETICS, 27, 704 - 704

Correction: Delivering genomic medicine in the UK National Health Service: a systematic review and narrative synthesis.

Pearce C. et al, (2019), Genet Med

Lay Perspectives on Receiving Different Types of Genomic Secondary Findings: a Qualitative Vignette Study.

Vornanen M. et al, (2019), J Genet Couns, 28, 343 - 354

Negotiating jurisdictional boundaries in response to new genetic possibilities in breast cancer care: The creation of an 'oncogenetic taskscape'.

Wright S. et al, (2019), Soc Sci Med, 225, 26 - 33

Moving into the mainstream: healthcare professionals' views of implementing treatment focussed genetic testing in breast cancer care.

Hallowell N. et al, (2019), Familial cancer

How should decision aids be used during counseling to help patients who are "genetically at risk"?

Evans N. et al, (2019), AMA Journal of Ethics, 21, 865 - 872

Lay perspectives on receiving different types of genomic secondary findings: a qualitative vignette study

Vornanen M. et al, (2018), Journal of Genetic Counseling

High-Risk Women’s Risk Perception After Receiving Personalized Polygenic Breast Cancer Risk Information

Forrest L. et al, (2018), Journal of Community Genetics

"I would like to discuss it further with an expert": a focus group study of Finnish adults' perspectives on genetic secondary findings.

Vornanen M. et al, (2018), J Community Genet, 9, 305 - 314

Research or clinical care: what's the difference?

(2018), Journal of medical ethics

Patients' Views of Treatment-Focused Genetic Testing (TFGT): Some Lessons for the Mainstreaming of BRCA1 and BRCA2 Testing.

Wright S. et al, (2018), Journal of genetic counseling, 27, 1459 - 1472

A pragmatic group sequential, placebo-controlled, randomised trial to determine the effectiveness of glyceryl trinitrate for retained placenta (GOT-IT): a study protocol.

Denison FC. et al, (2017), BMJ open, 7, e017134 - e017134

Written versus verbal consent: a qualitative study of stakeholder views of consent procedures used at the time of recruitment into a peripartum trial conducted in an emergency setting.

Lawton J. et al, (2017), BMC Med Ethics, 18, 36 - 36

Staff experiences of closing out a clinical trial involving withdrawal of treatment: qualitative study

White D. et al, (2017), TRIALS, 18

A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.

Heller S. et al, (2017), Health Technol Assess, 21, 1 - 278

Load More

1
2
3
4
5
6
7

Include forthcoming?